Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PEPPERMINT INNOVATION LIMITED Capital/Financing Update 2018

Dec 20, 2018

65563_rns_2018-12-20_f97802ff-51da-42e6-b452-76dfb0e9b258.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Appendix 3B New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

Peppermint Innovation Limited

ABN 56 125 931 964

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or to be
issued
2
Number of+securities issued or to
be issued (if known) or maximum
number which may be issued
Convertible notes
Convertible notes - $250,000
  • See chapter 19 for defined terms.

Appendix 3B Page 1

04/03/2013

Appendix 3B New issue announcement

3 Principal terms of the[+] securities Convertible notes maturing on 21 December (e.g. if options, exercise price and 2019 bearing 12% interest per annum, from the expiry date; if partly paid date of receipt of funds, payable within 5 days of +securities, the amount outstanding maturity unless redeemed or converted earlier, and due dates for payment; if and convertible into fully paid ordinary shares at +convertible securities, the $0.025 per share. conversion price and dates for conversion) The Company is entitled to convert all (but not some) of the Convertible Notes at any time after the first anniversary of the issue of the Convertible Notes if the VWAP for each of the 30 trading days ending not less than 5 trading days before the date of issue of the Issuer Conversion Notice is at $0.0325. The Convertible Notes are secured by the Company’s 100% owned subsidiary Zambian Copper Pty Ltd, which holds the Company’s mineral exploration project in Zambia.

  • See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

4
Do the+securities rank equally in
all respects from the+issue date
with an existing+class of quoted
+securities?
If the additional+securities do not
rank equally, please state:
 the date from which they do
 the extent to
which they
participate
for
the
next
dividend, (in the case of a trust,
distribution) or interest payment
 the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest payment
5
Issue price or consideration
6
Purpose of the issue
(If issued as consideration for the
acquisition
of
assets,
clearly
identify those assets)
6a
Is the entity an+eligible entity that
has
obtained
security
holder
approval under rule 7.1A?
If Yes, complete sections 6b – 6h_in_
relation to the+securities the
subject of this Appendix 3B, and
comply with section 6i
6b
The date the security holder
resolution under rule 7.1A was
passed
6c
Number
of
+securities
issued
without security holder approval
under rule 7.1
6d
Number of+securities issued with
security holder approval under rule
7.1A
No, unless converted at which time they will
rank equally with fully paid ordinary shares.
Convertible Notes - $250,000
Working capital
No
N/A
Nil, unless converted in which case 10,000,000
ordinary shares will be issued
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 3

04/03/2013

6e
Number of+securities issued with
security holder approval under rule
7.3, or another specific security
holder approval (specify date of
meeting)
6f
Number of+securities issued under
an exception in rule 7.2
6g
If+securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
+issue date and both values.
Include the source of the VWAP
calculation.
6h
If+securities were issued under rule
7.1A for non-cash consideration,
state date on which valuation of
consideration was released to ASX
Market Announcements
6i
Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and
release
to
ASX
Market
Announcements
7
+Issue dates
Note: The issue date may be prescribed by ASX
(refer to the definition of issue date in rule 19.12).
For example, the issue date for a pro rata
entitlement issue must comply with the applicable
timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
8
Number and+class of all+securities
quoted on ASX (_including_the
+securities
in
section
2
if
applicable)
N/A
N/A

N/A
N/A
7.1 –27,259,029
7.1A – N/A
21 December 2018
Number +Class
987,582,463 Fully paid ordinary
shares
  • See chapter 19 for defined terms.

Appendix 3B Page 4

04/03/2013

9
Number and+class of all+securities
not quoted on ASX (_including_the
+securities
in
section
2
if
applicable)
Number +Class
100,000,000
10,000,000
10,000,000
10,000,000
Performance
shares
subject to the terms
and conditions as set
out in the Notice of
General Meeting held
on 2 Oct 2015.
Options
to
acquire
fully
paid
ordinary
shares at 3 cents each
expiring on 27 August
2020, exercisable after
the 30 day volume
weighted average price
of fully paid ordinary
shares is 5 cents or
more;
Options
to
acquire
fully
paid
ordinary
shares at 3 cents each,
expiring on 27 August
2020, exercisable after
the 30 day volume
weighted average price
of fully paid ordinary
shares is 10 cents or
more;
Options to vest on 28
December
2018
to
acquire
fully
paid
ordinary shares at 5
cents each, expiring on
27
August
2020,
exercisable after the 30
day volume weighted
average price of fully
paid ordinary shares
share price is 15 cents
or more; and
  • See chapter 19 for defined terms.

Appendix 3B Page 5

04/03/2013

10,000,000 Options to vest on 28
February
2019
to
acquire
fully
paid
ordinary shares at 5
cents each, expiring on
27
August
2020,
exercisable after the 30
day volume weighted
average price of fully
paid ordinary shares
share price is 20 cents
or more.
Equivalent
to
10,000,000
ordinary
shares
Convertible
notes
maturing
on
21
December
2019
bearing 12% interest
per annum, from the
date
of
receipt
of
funds, payable within 5
days of maturity unless
redeemed or converted
earlier, and convertible
into fully paid ordinary
shares at $0.025 per
share.
The Company is
entitled to convert all
(but not some) of the
Convertible Notes at
any time after the first
anniversary of the
issue of the
Convertible Notes if
the VWAP for each of
the 30 trading days
ending not less than 5
trading days before the
date of issue of the
Issuer Conversion
Notice is at $0.0325.
The Convertible Notes
are secured by the
Company’s 100%
owned subsidiary
Zambian Copper Pty
Ltd, which holds the
Company’s mineral
exploration project in
Zambia.
  • See chapter 19 for defined terms.

Appendix 3B Page 6

04/03/2013

10 Dividend policy (in the case of a N/A trust, distribution policy) on the increased capital (interests)

Part 2 - Pro rata issue

11 Is security holder approval required?
12 Is the issue renounceable or non-
renounceable?
13 Ratio in which the+securities will be
offered
14 +Class of+securities to which the
offer relates
15 +Record
date
to
determine
entitlements
16 Will holdings on different registers
(or subregisters) be aggregated for
calculating entitlements?
17 Policy for deciding entitlements in
relation to fractions
18 Names of countries in which the
entity has security holders who will
not be sent new offer documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19 Closing
date
for
receipt
of
acceptances or renunciations
  • See chapter 19 for defined terms.

Appendix 3B Page 7

04/03/2013

20 Names of any underwriters
21 Amount of any underwriting fee or
commission
22 Names of any brokers to the issue
23 Fee or commission payable to the
broker to the issue
24 Amount of any handling fee payable
to brokers who lodge acceptances or
renunciations on behalf of security
holders
25 If the issue is contingent on security
holders’ approval, the date of the
meeting
26 Date entitlement and acceptance
form and offer documents will be
sent to persons entitled
27 If the entity has issued options, and
the terms entitle option holders to
participate on exercise, the date on
which notices will be sent to option
holders
28 Date rights trading will begin (if
applicable)
29 Date rights trading will end (if
applicable)
30 How do security holders sell their
entitlements_in full_through a
broker?
31 How do security holders sell_part_of
their entitlements through a broker
and accept for the balance?
  • See chapter 19 for defined terms.

Appendix 3B Page 8

04/03/2013

32 How do security holders dispose of their entitlements (except by sale through a broker)?

  • 33 +Issue date

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

34 Type of[+] securities ( tick one )

  • (a) +Securities described in Part 1

(b) All other[+] securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

  • 35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

37 A copy of any trust deed for the additional[+] securities

  • See chapter 19 for defined terms.

Appendix 3B Page 9

04/03/2013

Entities that have ticked box 34(b)

38
Number of+securities for which
+quotation is sought
39
+Class of
+securities for which
quotation is sought
40
Do the+securities rank equally in all
respects from the+issue date with an
existing+class of quoted+securities?
If the additional+securities do not
rank equally, please state:
 the date from which they do
 the
extent
to
which
they
participate for the next dividend,
(in
the
case
of
a
trust,
distribution) or interest payment
 the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest payment
41
Reason for request for quotation now
Example: In the case of restricted securities, end of
restriction period
(if issued upon conversion of another
+security, clearly identify that other
+security)
42
Number and+class of all+securities
quoted on ASX (_including_the
+securities in clause 38)
Number +Class
  • See chapter 19 for defined terms.

Appendix 3B Page 10

04/03/2013

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted[+] quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: Date: 21/12/2018 (Executive Director/Company secretary) Print name: Anthony Kain == == == == ==

  • See chapter 19 for defined terms.

Appendix 3B Page 11

04/03/2013

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

==> picture [404 x 407] intentionally omitted <==

----- Start of picture text -----

Insert number of fully paid [+] ordinary 925,949,092
securities on issue 12 months before the
+ issue date or date of agreement to issue
Add the following: Nil
• Number of fully paid [+] ordinary
securities issued in that 12 month
period under an exception in rule 7.2
• Number of fully paid [+] ordinary
securities issued in that 12 month
period with shareholder approval
• Number of partly paid [+] ordinary
securities that became fully paid in that
12 month period
Note:
• Include only ordinary securities here –
other classes of equity securities
cannot be added
• Include here (if applicable) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as
separate line items
Subtract the number of fully paid Nil
+ ordinary securities cancelled during that
12 month period
“A” 925,949,092
----- End of picture text -----

  • See chapter 19 for defined terms.

Appendix 3B Page 12

04/03/2013

Step 2: Calculate 15% of “A”

Step 2: Calculate 15% of “A” Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply“A” by 0.15 138,892,363
Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used
Insertnumber of+equity securities issued
or agreed to be issued in that 12 month
period_not counting_those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under
rule 7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as
separate line items
17,500,000(under the placement which is
the subject of the Appendix 3B dated 9
February 2018)
40,000,000 (under the issue of options
which is the subject of the Appendix 3B
dated 9 February 2018)
6,666,667 (under the placement which is
the subject of the Appendix 3B dated 26
April 2018)
3,333,333 (under the placement which is
the subject of the Appendix 3B dated 18
May 2018)
12,333,334 (under the placement which is
the subject of the Appendix 3B dated 2
August 2018)
11,000,000 (under the placement which is
the subject of the Appendix 3B dated 27
August 2018)
6,800,000 (under the placement which is
the subject of the Appendix 3B dated 6
September 2018)
4,000,000 (under the placement which is
the subject of the Appendix 3B dated 19
November 2018)
10,000,000 (under the issue of convertible
notes which is the subject of this Appendix
3B dated 18 December 2018)
“C” 111,633,334
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15
Note: number must be same as shown in
Step 2
138,892,363
Step 2: Calculate 15% of “A” Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply“A” by 0.15 138,892,363
Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used
Insertnumber of+equity securities issued
or agreed to be issued in that 12 month
period_not counting_those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under
rule 7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as
separate line items
17,500,000(under the placement which is
the subject of the Appendix 3B dated 9
February 2018)
40,000,000 (under the issue of options
which is the subject of the Appendix 3B
dated 9 February 2018)
6,666,667 (under the placement which is
the subject of the Appendix 3B dated 26
April 2018)
3,333,333 (under the placement which is
the subject of the Appendix 3B dated 18
May 2018)
12,333,334 (under the placement which is
the subject of the Appendix 3B dated 2
August 2018)
11,000,000 (under the placement which is
the subject of the Appendix 3B dated 27
August 2018)
6,800,000 (under the placement which is
the subject of the Appendix 3B dated 6
September 2018)
4,000,000 (under the placement which is
the subject of the Appendix 3B dated 19
November 2018)
10,000,000 (under the issue of convertible
notes which is the subject of this Appendix
3B dated 18 December 2018)
“C” 111,633,334
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15
Note: number must be same as shown in
Step 2
138,892,363
  • See chapter 19 for defined terms.

Appendix 3B Page 13

04/03/2013

Subtract“C”
Note: number must be same as shown in
Step 3
111,633,334
Total[“A” x 0.15] – “C” 27,259,029
[Note: this is the remaining placement
capacity under rule 7.1]
  • See chapter 19 for defined terms.

Appendix 3B Page 14

04/03/2013

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

“A”

Note: number must be same as shown in Step 1 of Part 1

Step 2: Calculate 10% of “A”

“D” 0.10

Note: this value cannot be changed

Multiply “A” by 0.10

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

Insert number of[+] equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

  • This applies to equity securities – not just ordinary securities

  • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed

  • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

  • It may be useful to set out issues of securities on different dates as separate line items

“E”

  • See chapter 19 for defined terms.

Appendix 3B Page 15

04/03/2013

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
“A” x 0.10
Note: number must be same as shown in
Step 2
Subtract“E”
Note: number must be same as shown in
Step 3
Total[“A” x 0.10] – “E” Note: this is the remaining placement
capacity under rule 7.1A
  • See chapter 19 for defined terms.

Appendix 3B Page 16

04/03/2013